One may be forgiven for being unaware of cannabinoids other than
THC and CBD. THC is famous, of course, for providing the
intoxicating effect of marijuana, whereas CBD has bloomed in
popular awareness following passage of the 2018 Farm Bill, which
removed hemp-derived CBD from the Controlled Substances Act. With
more than 120 identified cannabinoid compounds found in the plant
genus Cannabis, it's all but certain that products based on
cannabinoids other than THC and CBD will become better known. The
two most likely contenders are cannabigerol, or CBG, and
cannabinol, or CBN.
The U.S. Food and Drug Administration continues to explore
potential pathways for various types of CBD products to be lawfully
marketed. In the wake of new warning letters sent to 15 CBD
companies that were issued on November 25, 2019, the FDA has
announced that it "plans to provide an update on its progress
regarding the agency's approach to these products in the coming
weeks." Similar to CBD,
